Skip to main content

Table 1 Population characteristics for patients with documented systolic dysfunction

From: Retrospective review of in hospital use of mineralocorticoid receptor antagonists for high risk patients following myocardial infarction

   Eligible (n = 332) Ineligible (n = 1142)
Demographics Male (%) 250 (75.3 %) 842 (73.7 %)
Age (years) 67.6 +/− 12.8 64.7+/− 13.2
Length of stay (days) 15 +/− 21 9 +/− 13
Medical history Hypertension 199 (59.9 %) 624 (54.6 %)
Dyslipidemia 132 (39.8 %) 407 (35.6 %)
Diabetes 187 (56.3 %) 272 (23.8 %)
Smoking 107 (32.2 %) 399 (34.9 %)
Myocardial infarction 117 (35.2 %) 257 (22.5 %)
Heart failure 86 (25.9 %) 77 (6.7 %)
Clinical data Systolic blood pressure (mmHg) 114 +/−18 119 +/− 23
Heart rate (beats/min) 78 +/− 15 72 +/− 14
Ejection fraction 32.7 +/− 7.1 45.6+/− 6.9
STEMI 141 (42.5 %) 637 (55.8 %)
Laboratory data Peak troponin T (μg/L) 4.0 +/− 5.9 3.7+/− 4.9
Peak potassium (mmol/L) 4.5 +/− 0.4 4.5 +/− 0.5
Estimated GFR (mL/min/1.73 m2) 81 +/− 36 77 +/− 30
  1. EF ejection fraction, μg/L micrograms per liter, μmol/L micromole per liter, mmHg millimeters mercury, mmol/L millimoles per liter, STEMI ST elevation myocardial infarction. All numerical values shown +/− standard deviation